Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-03-09FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Rosuvastatin Calcium from Rising Pharma Holdings, Inc., enabling this rosuvastatin calcium g…
-
FDA approval · 2020-02-26FDA Approved: NEXLIZET — Original Application (Esperion Therapeutics, Inc.)
The FDA approved Nexlizet, a fixed-dose combination of bempedoic acid and ezetimibe, for adults with primary hyperlipidemia (including heter…
-
FDA approval · 2020-02-21FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Rosuvastatin Calcium from Quallent Pharmaceuticals Health LLC, establishing a generic rosuvastat…
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: A Mobile Personal Health Record for Behavioral Health Homes [NA]
Completed clinical trial evaluating a mobile personal health record for behavioral health homes; results posted in 2020.
-
FDA approval · 2020-01-29FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Dr.Reddys Laboratories Inc)
The FDA approved a supplemental application for the generic fixed-dose combination ezetimibe and simvastatin by Dr. Reddy's Laboratories. Th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-01-29FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for the ezetimibe and simvastatin fixed-dose combination developed by Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2020-01-29FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for the ezetimibe and simvastatin combination product from Ascend Laboratories LLC.
-
FDA approval · 2020-01-24FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's supplemental application for a generic ezetimibe and simvastatin combination product, expanding access to this lipid…
-
FDA approval · 2019-12-18FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the amlodipine besylate and atorvastatin calcium combination product, submitted by Prasco Labora…
-
FDA approval · 2019-12-09FDA Approved: FENOFIBRATE — Supplemental Application (Apotex Corp.)
The FDA approved Apotex Corp.'s supplemental application for fenofibrate (generic) under ANDA 202252.
-
FDA approval · 2019-11-26FDA Approved: GEMFIBROZIL — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for Gemfibrozil submitted by Exelan Pharmaceuticals, Inc., likely updating the product labeling.
-
FDA approval · 2019-11-18FDA Approved: AMLODIPINE AND ATORVASTATIN — Original Application (Apotex Corp.)
FDA approved the original application for a generic fixed-dose combination of amlodipine and atorvastatin, manufactured by Apotex Corp., for…
-
FDA label_change · 2019-11-06FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the amlodipine/atorvastatin combination by Mylan Pharmaceuticals, resulting in labeling changes …
-
FDA approval · 2019-11-04FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Zhejiang Yongtai Pharmaceutical Co., Ltd.)
FDA approves rosuvastatin calcium as a generic drug (Original Application) by Zhejiang Yongtai Pharmaceutical Co., Ltd.
-
FDA approval · 2019-10-30FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for fenofibrate, bringing a generic fenofibrate product to approval status.
-
FDA approval · 2019-10-25FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Novadoz Pharmaceuticals LLC)
The FDA approved a supplemental application for atorvastatin calcium from Novadoz Pharmaceuticals LLC, authorizing its continued availabilit…
-
FDA approval · 2019-10-25FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's supplemental application for fenofibrate (generic fenofibrate) under ANDA209950, resulting …
-
FDA approval · 2019-10-22FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium from Dr. Reddy's Laboratories Limited under an ANDA to enable continued mar…
-
FDA approval · 2019-10-22FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium from Dr. Reddy's Laboratories Limited, allowing the generic product to be m…
-
FDA approval · 2019-10-21FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Cipla USA Inc.,)
The FDA approved Cipla USA Inc.'s Supplemental Application for atorvastatin calcium, making a generic atorvastatin calcium product an approv…
-
FDA approval · 2019-10-18FDA Approved: LIVALO — Supplemental Application (Kowa Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for LIVALO (pitavastatin calcium) submitted by Kowa Pharmaceuticals America, Inc.
-
FDA approval · 2019-10-18FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for ATORVASTATIN CALCIUM submitted by Zydus Lifesciences Limited (ANDA 206536).
-
FDA approval · 2019-10-16FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for atorvastatin calcium, a generic statin used to treat high cholesterol, unde…
-
FDA approval · 2019-10-11FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application to market atorvastatin calcium as a generic version of atorvastatin.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: The Health Access and Recovery Peer Program [NA]
Clinical trial update for the Health Access and Recovery Peer Program; study completed with posted results.